Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease

被引:169
作者
Lehmann, DJ
Johnston, C
Smith, AD
机构
[1] UNIV OXFORD, DEPT PHARMACOL, OPTIMA, OXFORD OX1 3QT, ENGLAND
[2] RADCLIFFE INFIRM, OXFORD OX2 6HE, ENGLAND
关键词
D O I
10.1093/hmg/6.11.1933
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The allelic frequency of the gene for the K variant of butyrylcholinesterase (BCHE-K) was 0.17 in 74 subjects with fate-onset (age >65 years) histopathologically diagnosed Alzheimer's disease (AD), which was higher than the frequencies in 104 elderly control subjects (0.09), in 14 early-onset cases of confirmed AD (0.07) and in 29 confirmed cases of other dementia (0.10), The association of BCHE-K with late-onset AD was limited to carriers of the epsilon 4 allele of the apolipoprotein E gene (APOE), among whom the presence of BCHE-K gave an odds ratio of confirmed late-onset AD of 6.9 (95% C.I. 1.65-29) in subjects >65 years and of 12.8 (1.9-86) in subjects >75 years, In APOE epsilon 4 carriers over 75 years, only 1/22 controls, compared with 10/24 confirmed late-onset AD cases, had BCHE-K, We suggest that BCHE-K, or a nearby gene on chromosome 3, acts in synergy with APOE epsilon 4 as a susceptibility gene for late-onset AD.
引用
收藏
页码:1933 / 1936
页数:4
相关论文
共 43 条
[1]  
BARTELS CF, 1992, AM J HUM GENET, V50, P1086
[2]   ELECTRON-MICROSCOPIC LOCALIZATION OF CHOLINESTERASE ACTIVITY IN ALZHEIMER BRAIN-TISSUE [J].
CARSON, KA ;
GEULA, C ;
MESULAM, MM .
BRAIN RESEARCH, 1991, 540 (1-2) :204-208
[3]   NEUROPATHOLOGICAL CHANGES IN SCRAPIE AND ALZHEIMERS-DISEASE ARE ASSOCIATED WITH INCREASED EXPRESSION OF APOLIPOPROTEIN-E AND CATHEPSIN-D IN ASTROCYTES [J].
DIEDRICH, JF ;
MINNIGAN, H ;
CARP, RI ;
WHITAKER, JN ;
RACE, R ;
FREY, W ;
HAASE, AT .
JOURNAL OF VIROLOGY, 1991, 65 (09) :4759-4768
[4]   ON THE IDENTIFICATION AND FREQUENCY OF THE J AND K CHOLINESTERASE PHENOTYPES IN A CAUCASIAN POPULATION [J].
EVANS, RT ;
WARDELL, J .
JOURNAL OF MEDICAL GENETICS, 1984, 21 (02) :99-102
[5]   REFINEMENT OF THE LOCALIZATION OF HUMAN BUTYRYLCHOLINESTERASE TO CHROMOSOME 3Q26.1-Q26.2 USING A PCR-DERIVED PROBE [J].
GAUGHAN, G ;
PARK, H ;
PRIDDLE, J ;
CRAIG, I ;
CRAIG, S .
GENOMICS, 1991, 11 (02) :455-458
[6]   CHOLINESTERASES AND THE PATHOLOGY OF ALZHEIMER-DISEASE [J].
GEULA, C ;
MESULAM, MM .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1995, 9 :23-28
[7]   ULTRASTRUCTURAL-LOCALIZATION OF BUTYRYLCHOLINESTERASE ON NEUROFIBRILLARY DEGENERATION SITES IN THE BRAINS OF AGED AND ALZHEIMERS-DISEASE PATIENTS [J].
GOMEZRAMOS, P ;
BOURAS, C ;
MORAN, MA .
BRAIN RESEARCH, 1994, 640 (1-2) :17-24
[8]   Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].
Hofman, A ;
Ott, A ;
Breteler, MMB ;
Bots, ML ;
Slooter, AJC ;
vanHarskamp, F ;
vanDuijn, CN ;
Van Broeckhoven, C ;
Grobbee, DE .
LANCET, 1997, 349 (9046) :151-154
[9]   LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN MEDIATES APOLIPOPROTEIN E-DEPENDENT NEURITE OUTGROWTH IN A CENTRAL NERVOUS SYSTEM-DERIVED NEURONAL CELL-LINE [J].
HOLTZMAN, DM ;
PITAS, RE ;
KILBRIDGE, J ;
NATHAN, B ;
MAHLEY, RW ;
BU, GJ ;
SCHWARTZ, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (21) :9480-9484
[10]   Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site [J].
Jensen, FS ;
Nielsen, LR ;
Schwartz, M .
HUMAN HEREDITY, 1996, 46 (01) :26-31